Secai Secures $6.2M Series A Funding
Secai, a Montreal, Canada-based healthcare technology company, has raised $6.2 million in Series A funding.
Secai, a Montreal, Canada-based healthcare technology company, has raised $6.2 million in Series A funding.
Investors
The round included healthcare-focused investors and strategic partners with expertise in clinical operations, EMR integrations, and large-scale health system deployment.
Secai Use of Funds
The funding will support the commercial expansion of Voxira and NoteGen, strengthen engineering and product capabilities, deepen EMR integrations, and advance R&D in clinical reasoning and agentic workflows.
About Secai
Secai is a health AI company focused on closing the gap between advanced technology and daily clinical practice. Its platforms, Voxira and NoteGen, deliver autonomous voice reception, patient access automation, and real-time encounter documentation integrated directly into electronic medical records (EMRs). Certified by the Quebec Ministry of Health, Secai's tools are built for practical, reliable use, helping clinics run smoothly and giving patients faster, easier access to care.
Funding Details
Company: Secai, Inc.
Raised: $6.2M
Round: Series A
Funding Date: February 2026
Lead Investor: Undisclosed
Additional Investors: Undisclosed
Company Website: https://secai.ca/
Software Category: Healthcare AI / Clinical Automation and Documentation
